1. A significant decrease in circulating B and CD8+CD28- cells.2.An increase in CD8+ cells expressing CD71+ and CD28+ in AD patients.3.A significant decrease in IL-10 production after stimulation of PMBC with Abeta. Here, TFRC is linked to Alzheimer disease.